Cetera Investment Advisers »

Taysha Gene Therapies shares owned by Cetera Investment Advisers

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Cetera Investment Advisers from 13F filings

Historical chart of Cetera Investment Advisers investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Cetera Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Cetera Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $53k 16k 3.27

More positions owned by Cetera Investment Advisers

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)

View all positions for Cetera Investment Advisers

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
Morgan Stanley
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings

View all funds holding Taysha Gene Therapies